Tristel (LSE:TSTL) Debt-to-Equity : 0.19 (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Tristel Debt-to-Equity?

Tristel's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was £0.81 Mil. Tristel's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was £5.14 Mil. Tristel's Total Stockholders Equity for the quarter that ended in Dec. 2023 was £31.12 Mil. Tristel's debt to equity for the quarter that ended in Dec. 2023 was 0.19.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Tristel's Debt-to-Equity or its related term are showing as below:

LSE:TSTL' s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.2 Max: 0.21
Current: 0.19

During the past 13 years, the highest Debt-to-Equity Ratio of Tristel was 0.21. The lowest was 0.00. And the median was 0.20.

LSE:TSTL's Debt-to-Equity is ranked better than
52.71% of 700 companies
in the Medical Devices & Instruments industry
Industry Median: 0.22 vs LSE:TSTL: 0.19

Tristel Debt-to-Equity Historical Data

The historical data trend for Tristel's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tristel Debt-to-Equity Chart

Tristel Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Debt-to-Equity

Get a 7-Day Free Trial

0.21

0.20

0.17

Tristel Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.21	0.20	0.20	0.17	0.19

Competitive Comparison of Tristel's Debt-to-Equity

For the Medical Instruments & Supplies subindustry, Tristel's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tristel's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tristel's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Tristel's Debt-to-Equity falls into.

Tristel Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Tristel's Debt to Equity Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.859	+	4.321)	/	30.677
	=	0.17

Tristel's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.814	+	5.139)	/	31.122
	=	0.19

Tristel (LSE:TSTL) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Tristel Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Tristel's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Tristel (LSE:TSTL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tristel PLC (LSE:TSTL) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

R1V:Germany

Address

Fordham Road, Unit 1B, Lynx Business Park, Newmarket, Snailwell, Cambridgeshire, GBR, CB8 7NY

Website

https://tristelgroup.com

Tristel PLC is a player in the healthcare platform. The company is a manufacturer of chlorine dioxide chemistry used for the decontamination of medical devices. Its operating segments include three sectors, Hospital medical device decontamination products which are used predominantly for infection control in hospitals; manufacture and sale of hospital environmental surface disinfection products; and pharmaceutical and personal care product manufacturing industries, veterinary and animal welfare. The company generates majority of revenue from Hospital medical device decontamination.

Tristel (LSE:TSTL) Headlines

No Headlines